Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

FOREWARN to Provide Identity Verification Services to Pacific West Association of REALTORS® to Promote Agent Safety

FOREWARN to Provide Identity Verification Services to Pacific West Association of REALTORS® to Promote Agent Safety

red violet, Inc.'s subsidiary FOREWARN has announced a collaboration with Pacific West Association of REALTORS® to provide FOREWARN's real-time identity verification services to over 10,000 members across California. The service, accessible online and via mobile app, enables real estate agents to verify identities, check criminal histories, and val…

Asure’s 2026 HR Benchmark Report Finds Compliance Confidence Collapsing at America’s Small Businesses

Asure’s 2026 HR Benchmark Report Finds Compliance Confidence Collapsing at America’s Small Businesses

Asure Software's 2026 HR Benchmark Report reveals that small business owners are increasingly uncertain about their compliance with employment laws, especially those experiencing downturns. The company emphasizes that growing businesses are more proactive in HR best practices and promotes its AsureWorks managed service to help alleviate compliance …

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

Adagene Inc., a clinical-stage biotechnology company, announced the achievement of a preclinical milestone with Exelixis relating to its SAFEbody platform. This milestone pertains to the development of XB404, an antibody-drug conjugate targeting ROR1/2-expressing tumors, which triggered a $2 million payment from Exelixis. Additional payments were a…

Ascent Solar Technologies Expands Commercial and Defense Industry Expertise with Strategic Leadership Appointments

Ascent Solar Technologies Expands Commercial and Defense Industry Expertise with Strategic Leadership Appointments

Ascent Solar Technologies has appointed Tom Bawol as Director of Strategic Sales & Market Development and LTG Steve Smith as Strategic Advisor, bringing extensive military leadership and business development experience. These appointments aim to accelerate the commercial adoption of Ascent's flexible thin-film photovoltaic solutions in markets such…

PowerCompute Announces August 2026 Production and Operational Update

PowerCompute Announces August 2026 Production and Operational Update

PowerCompute, Inc. provided an operational update for August 2026, highlighting consistent Bitcoin mining production of 7.9 BTC, energy sales generated through power curtailment amounting to approximately $132,000, and bitcoin holdings value of $25.2 million. The company is advancing its mining capabilities by ordering 1,000 new miners, anticipatin…

NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors

NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company focused on CNS cancer therapies, announced a $15 million registered direct offering of common stock and warrants at a combined price of $4.20 per share. The offering targets new and existing healthcare-focused institutional investors and is expected to close around Septem…

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position

Incannex Healthcare has started dosing patients in its Phase 2 dose-optimization trial (DReAMzz) of IHL-42X for obstructive sleep apnea, following positive prior Phase 2 data and FDA Fast Track designation. The company also received a US patent covering IHL-42X composition expiring in 2040 and holds approximately $70 million in cash with no debt. A…

Weight Watchers Appoints Stephen Bye as Chief Executive Officer

Weight Watchers Appoints Stephen Bye as Chief Executive Officer

WW International, Inc., known for its science-backed weight management programs, announced the appointment of Stephen Bye as its new President and CEO. Bye brings over 30 years of leadership experience in consumer subscription and technology businesses, having previously led Ookla and held senior roles at DISH Network, Sprint, and others. His exper…

HP Extends Data-Center AI Architecture to the Edge

HP Extends Data-Center AI Architecture to the Edge

HP Inc. announced a collaboration with Red Hat and NVIDIA to develop an open, enterprise-grade AI platform combining HP's ZGX Fury hardware with Red Hat AI Factory and NVIDIA's AI technology. This platform is designed to run AI inference closer to users, machines, and data, enabling improved AI performance, reduced setup times, and enhanced operati…

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Serina Therapeutics announced the Safety Monitoring Committee's recommendation to proceed to Cohort 2 in its Phase 1b registrational study of SER-252 for advanced Parkinson's disease after favorable blinded safety, tolerability, and pharmacokinetic data from Cohort 1. Early exploratory clinical observations indicated sustained motor function improv…

SL Green Announces Sale of 110 Greene Street for $226 Million

SL Green Announces Sale of 110 Greene Street for $226 Million

SL Green Realty Corp., Manhattan's largest office landlord, announced the sale of its 110 Greene Street office building in SoHo to Natora Group for $226 million. The transaction is expected to close in Q4 2026, generating approximately $216 million in net cash proceeds to repay unsecured corporate debt. The building was brought to full occupancy wi…

Rail Vision Introduces TrackScout and YardFlow Flex as New Brand Names for its Mainline and Switchyard Solutions

Rail Vision Introduces TrackScout and YardFlow Flex as New Brand Names for its Mainline and Switchyard Solutions

Rail Vision Ltd. announced the rebranding of its MainLine and ShuntingYard AI-powered railway safety products to TrackScout and YardFlow Flex, respectively. These advanced AI perception systems enhance hazard detection and operational efficiency in mainline rail networks and industrial rail yards, supported by Rail Vision's operational intelligence…

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Helus Pharma, a clinical-stage pharmaceutical company focusing on novel serotonergic agonists (NSAs) for mental health conditions, announced that its CEO Michael Halstead will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference. The company is advancing its lead compounds HLP003 in Phase 3 for major depres…

FTI Consulting Strengthens Construction Disputes Capabilities in Latin America With Appointment of Luis Roman

FTI Consulting Strengthens Construction Disputes Capabilities in Latin America With Appointment of Luis Roman

FTI Consulting, Inc. has appointed Luis Roman as Senior Managing Director to strengthen its Construction, Projects & Assets practice, particularly in Latin America. Mr. Roman brings over 30 years of construction and project management experience with expertise in construction forensics and dispute resolution. His appointment aims to support clients…

NervGen to Host Inaugural R&D Day on September 30, 2026

NervGen to Host Inaugural R&D Day on September 30, 2026

NervGen, a NASDAQ-listed biopharmaceutical company, announced its inaugural R&D Day webcast to provide a comprehensive update on its lead neuroreparative drug candidate NVG-291. The event will feature detailed presentations on the science, clinical data, and upcoming Phase 3 RESTORE trial designed to treat chronic cervical spinal cord injury. Exper…

America's Car-Mart Reports First Quarter Fiscal Year 2027 Results

America's Car-Mart Reports First Quarter Fiscal Year 2027 Results

America’s Car-Mart, Inc. reported its first quarter fiscal 2027 financial results, showing severe declines in retail unit sales and revenue, primarily due to capital constraints limiting inventory purchases and finance receivables originations. The company sold 81.9% fewer retail units compared to the prior year, with inventory down 68.7%. The gros…

Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer

Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer

Palvella Therapeutics has appointed Dr. James R. Treat, a nationally recognized pediatric dermatologist with nearly 20 years of experience, as Chief Medical Officer. Dr. Treat has been a longstanding clinical collaborator and investigator in Palvella's QTORIN™ trials and will lead the company’s medical strategy as they advance the potential approva…